跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRi-1
首页
药物
TRi-1
TRi-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for preparing trimethylolpropane-tri (1-aziridinyl) propionate
申请人: UNIV NANCHANG HANGKONG
优先权: 2016
CN
Method for preparing tri(1-phenyl-isoquinoline) iridium (III)
申请人: UNIV KUNMING SCIENCE & TECHNOLOGY
优先权: 2016
CN
GLP-1/GCG/GIP tri-receptor agonists and uses thereof
申请人: GUANGDONG HEC PHARMACEUTICAL
优先权: 2022
CN
2 件公开
Method for preparing trimethylolpropane-tri-(2-methyl-1-aziridine) propionate
申请人: UNIV NANCHANG HANGKONG
优先权: 2016
CN
TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS
申请人: NOVO NORDISK AS
优先权: 2023
CN
US
2 件公开
GLUCAGON/GLP-1/GIP TRI-AGONISTS AND THEIR ASSOCIATED PRODRUGS
申请人: UNIV INDIANA RES & TECH CORP
优先权: 2024
WO
TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS
申请人: NOVO NORDISK AS
优先权: 2023
WO
Preparation method of 2, 4, 6-tri [(1, 1-biphenyl)-4-yl]-1, 3, 5-triazine
申请人: CHONGQING XINZHENGCHENG BIOLOGICAL MEDICINE CO LTD
优先权: 2024
CN
药物
反馈